Vaccine, measles


Concise Prescribing Info
Dosage Details
Subcutaneous
Active immunisation against measles
Child: 12-15 months 0.5 mL into the deltoid muscle. 2nd dose to be given at 4-6 years of age. In cases of measles outbreak: 0.5 mL at 6-11 months of age, 2nd dose at 12-15 months of age or 6 months after 1st dose. Booster dose to be given at 6 years of age.
Contraindications
Hypersensitivity to any component of the vaccine (e.g. egg protein, gelatin, neomycin). Severe anaphylactic reactions to previous dose of measles vaccine. Sudden illness with high grade fever, severe immunosuppression (e.g. agammaglobulinema), malignancies (e.g. leukemia, lymphoma), HIV infection, active TB. Recent administration of immunoglobulins and concomitant immunosuppressant therapy (e.g. radiation, chemotherapy, steroids). Pregnancy.
Special Precautions
Patient with history of cerebral injury; family or personal history of convulsions. Children. Lactation.
Adverse Reactions
Significant: Rarely, hypersensitivity reactions (e.g. rashes, urticaria, anaphylactic shock), subacute sclerosing panencephalitis (SSPE), febrile convulsions, thrombocytopenia.
Eye disorders: Eye infection.
Gastrointestinal disorders: Diarrhoea.
General disorders and administration site conditions: Fever.
Injury, poisoning and procedural complications: Rarely, inj site reactions e.g. pain, erythema.
Respiratory, thoracic and mediastinal disorders: Cough.
Skin and subcutaneous tissue disorders: Rarely, erythema multiforme, purpura.
Vascular disorders: Vasculitis.
Drug Interactions
Decreased effect with immunosuppressive agents (e.g. corticosteroids, antimetabolites), immune globulins, blood transfusion or products.
Lab Interference
Interfere with tuberculin test. May interfere with detection of HIV infection.
Action
Description: Measles vaccine is a preparation of live, attenuated measles virus. It is used for active immunisation against measles.
Storage
Store between 2-8°C. Protect from light.
Any unused portions should be disposed of in accordance with local requirements.
ATC Classification
J07BD01 - measles, live attenuated ; Belongs to the class of morbilli viral vaccines.
References
Anon. Measles Virus Vaccine Live. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 19/07/2018.

Buckingham R (ed). Measles Vaccine. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 19/07/2018.

Disclaimer: This information is independently developed by MIMS based on Vaccine, measles from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in